Back to TARS
Frazier Life Sciences Management, L.P. → TARS
Frazier Life Sciences Management, L.P. TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$56.6M
Q3 2026
Peak value
$59.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $59.7M |
| Q1 2026 | $51.1M |
| Q2 2026 | $45.9M |
| Q3 2026 | $56.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $56.6M | 720.3K | — | — |
| Q2 2026 | $45.9M | 728.6K | — | — |
| Q1 2026 | $51.1M | 728.6K | — | — |
| Q4 2025 | $59.7M | 728.6K | — | — |
Other funds holding TARS
$299.3M
$273.9M
$273.1M
$252.5M
$234.7M
$230.8M
$220.2M